DA
LLY icon

Drake & Associates’s Eli Lilly LLY Stock Holding History

Drake & Associates’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$614K Sell
667
-129
-16% -$131K 0.12% 64
2025
Q4 		$856K Sell
796
-77
-9% -$73.6K 0.17% 63
2025
Q3 		$809K Sell
873
-27
-3% -$20.1K 0.17% 67
2025
Q2 		$702K Buy
900
+54
+6% +$42K 0.17% 59
2025
Q1 		$699K Buy
846
+113
+15% +$94K 0.2% 49
2024
Q4 		$644K Sell
733
-646
-47% -$535K 0.18% 51
2024
Q3 		$1.22M Buy
1,379
+133
+11% +$120K 0.39% 23
2024
Q2 		$1.13M Sell
1,246
-113
-8% -$90.4K 0.4% 22
2024
Q1 		$1.06M Buy
1,359
+15
+1% +$10.7K 0.39% 24
2023
Q4 		$784K Sell
1,344
-436
-24% -$254K 0.32% 25
2023
Q3 		$956K Buy
1,780
+24
+1% +$12.4K 0.43% 23
2023
Q2 		$824K Sell
1,756
-24
-1% -$10.1K 0.37% 23
2023
Q1 		$611K Buy
1,780
+47
+3% +$15.9K 0.3% 28
2022
Q4 		$634K Buy
1,733
+83
+5% +$29.4K 0.34% 24
2022
Q3 		$534K Buy
1,650
+661
+67% +$209K 0.3% 21
2022
Q2 		$321K Buy
+989
New +$297K 0.18% 32

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Drake & Associates's LLY Position: Q1 2026 in Review

Drake & Associates reduced its Eli Lilly (LLY) stake by 16% in Q1 2026, selling an estimated $131K and leaving 667 shares worth $614K. The position accounts for 0.12% of the portfolio, ranked #64.

Drake & Associates first reported a position in LLY in Q2 2022 and has held it in 16 quarters since. The position peaked at $1.22M in Q3 2024. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Drake & Associates held 667 shares of Eli Lilly worth $614K as of Q1 2026.
  • Drake & Associates sold 129 Eli Lilly shares in Q1 2026, an estimated $131K.
  • Eli Lilly made up 0.12% of Drake & Associates's portfolio in Q1 2026, its #64 holding.
  • Drake & Associates first reported a position in Eli Lilly in Q2 2022 and has held it in 16 quarters since.
  • Drake & Associates's Eli Lilly position peaked at $1.22M in Q3 2024.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Drake & Associates's 13F filing for Q1 2026, filed 13 May 2026.